Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus
The Journal of Infectious Diseases · 2023
DOI: 10.1093/infdis/jiad025 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, 2023. Verfasst von Jaiprasath Sachithanandham und 7 weiteren Autor:innen. Beteiligte Einrichtung: W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Hepatitis C. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Mathematical models explain how antivirals control viral infections. Hepatitis C virus (HCV) treatment results in at least 2 phases of decline in viremia. The first phase reflects clearance of rapidly produced virions. The second phase is hypothesized to derive from loss of infected cells but has been challenging to prove.
Methods
Using single-cell methods, we quantified the number of hepatitis C virus (HCV)-infected hepatocytes in liver biopsies taken before and within 7 days of initiating direct-acting antivirals (DAAs) in a double-blinded randomized controlled trial testing 2 (sofosbuvir-velpatasvir) versus 3 (sofosbuvir-velpatasvir-voxilaprevir) DAAs.
Results
We employed thousands of intrahepatic measurements in 10 persons with chronic genotype 1a HCV infection: median proportion of infected hepatocytes declined from 11.3% (range, 1.3%–59%) to 0.6% (range, <0.3%–5.8%), a loss of 75%–95% infected hepatocytes. Plasma viremia correlated with numbers of HCV-infected hepatocytes (r = 0.77; P < .0001). Second-phase plasma dynamics and changes in infected hepatocytes were indistinct (P = .16), demonstrating that second-phase viral dynamics derive from loss of infected cells. DAAs led to a decline in intracellular HCV RNA and interferon-stimulated gene expression (P < .05 for both).
Conclusions
We proved that second-phase viral dynamics reflect decay of intrahepatic burden of HCV, partly due to clearance of HCV RNA from hepatocytes. Clinical Trials Registration NCT02938013.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Public Health, Baltimore, Maryland, USA.
- Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
- Applied Physics Laboratory, Johns Hopkins University, Laurel, Maryland, USA.
- Los Alamos National Laboratory, Los Alamos, New Mexico, USA.
Förderung
- NIAID NIH HHS
- NIDA NIH HHS
- National Institutes of Health
- Gilead Sciences
Zitieren
APA
Sachithanandham, J., Balagopal, A., Leep-Lazar, J., Quinn, J., Bowden, K., Ward, K., Ribeiro, R. M., & Sulkowski, M. S. (2023). Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad025
Vancouver
Sachithanandham J, Balagopal A, Leep-Lazar J, Quinn J, Bowden K, Ward K, et al. Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus. The Journal of Infectious Diseases. 2023. doi:10.1093/infdis/jiad025
BibTeX
@article{Sachithanandham2023,
author = {Sachithanandham, Jaiprasath and Balagopal, Ashwin and Leep-Lazar, Julia and Quinn, Jeffrey and Bowden, Kenneth and Ward, Kathleen and Ribeiro, Ruy M and Sulkowski, Mark S},
title = {Second-Phase Hepatitis C Plasma Viral Kinetics Directly Reflects Reduced Intrahepatic Burden of Hepatitis C Virus},
journal = {The Journal of Infectious Diseases},
year = {2023},
doi = {10.1093/infdis/jiad025}
}
EUVIMED